Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Type I interferons may help treat skin issues in lupus and dermatomyositis.

Mesenchymal stem cells may help treat hair loss by improving hair cell growth and reducing inflammation.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

IL-15 helps hair grow longer and stronger by extending the growth phase and reducing cell death.

Some small molecule antivirals show promise against COVID-19, but more research is needed to understand and improve them.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

The new microneedle patch effectively treats alopecia areata with fewer side effects than oral medication.

A new microneedle patch effectively promotes hair regrowth with less frequent dosing.

Understanding biological mediators in skin healing can improve treatments for skin wounds.

Targeting senescent cells may offer new treatments for PCOS.

Extracellular vesicles can help treat skin issues like wounds, hair loss, aging, and inflammation.

Chronic inflammation can cause cancer by making stem cells divide and mutate.

JAK inhibitors for alopecia areata have different safety risks, requiring specific monitoring for each drug.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

New treatments focusing on immune pathways show promise for stubborn hair loss.

Baricitinib is effective and safe for treating severe alopecia areata.

Janus kinase inhibitors are effective for severe alopecia areata, promoting hair regrowth.

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

Interleukin-15 can help hair growth and protect hair follicles.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

3D human skin models show promise for dermatology but face challenges in standardization and cost.

Stem cell therapies show promise for hair regrowth in alopecia areata but need more research for safety and effectiveness.

Combining hyperthermia with natural compounds and conventional treatments improves cancer therapy effectiveness and reduces side effects.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

Hemp seed-derived exosomes help restore feather growth in chickens affected by DHT.

New treatments are needed for non-scarring alopecia due to current limitations.

New treatments for hair loss show promise with advanced therapies and better targeting.